Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is a single-arm, open, exploratory clinical study to evaluate the efficacy of
carrelizumab (PD-1) combined with chemotherapy (SOX/XELOX) as neoadjuvant therapy and to
observe the changes of tumor immune microenvironment in patients with locally advanced
gastric or gastroesophageal junction cancer (T3-4NXM0).